HPV整合检测在HPV阳性妇女子宫颈病变分流管理中的潜在价值
前瞻性队列纳入157例高危型HPV阳性妇女,采用全基因组靶向捕获和高通量测序检测HPV整合。80.2%(126/157)检出整合,子宫颈癌为12/12,正常妇女为77%(24/31);HPV16整合在高级别病变中显著升高(P<0.001)。结论认为HPV整合检测有望优化筛查策略并利于精准分流管理。
要点
- 157例高危型HPV阳性样本中80.2%(126/157)检出HPV整合。
- 子宫颈癌HPV整合发生率为12/12,高于正常妇女的77%(24/31)。
- HPV16整合在CINⅢ为43%(18/42)、子宫颈癌为8/12,正常妇女为13%(4/31),P<0.001。
核心结论
- HPV整合事件与子宫颈病变进展显著相关,基于子宫颈脱落细胞的HPV整合检测有望优化现有筛查策略,减少HPV阳性妇女的过度干预并利于其精准分流管理。
研究设计与样本
- 采用前瞻性队列研究设计,纳入2022年7月至2024年7月于南京大学医学院附属鼓楼医院及南京市妇幼保健院接受子宫颈癌筛查的高危型HPV阳性妇女,共157例,包括正常31例、CINⅠ 40例、CINⅡ 32例、CINⅢ 42例、子宫颈癌12例。
- 收集子宫颈脱落细胞样本,应用HPV全基因组靶向捕获和高通量测序技术,分析HPV整合模式、宿主基因功能区域分布及通路富集特征。
主要发现
- 157例HR-HPV阳性样本中80.2%(126/157)检出HR-HPV整合;子宫颈癌患者整合发生率为12/12,高于正常妇女的77%(24/31)。
- HPV16型整合发生率在高级别病变中显著升高(P<0.001),CINⅢ患者为43%(18/42),子宫颈癌患者为8/12,正常妇女为13%(4/31)。
- 126例发生HPV整合的样本中共检出14 438个整合事件,整合位点主要分布于宿主基因间区(51.0%,7 359/14 438)和内含子区(38.1%,5 494/14 438),HPV病毒L1基因整合发生频率最高(28.4%,4 498/16 781)。
- HPV整合相关宿主基因显著富集于小分子转运、环磷酸鸟苷-蛋白激酶G信号通路、嘌呤核苷酸生物合成过程,通过多机制协同驱动癌变。
临床怎么用
- 作者认为,基于子宫颈脱落细胞的HPV整合检测有望优化现有筛查策略,减少HPV阳性妇女的过度干预并利于其精准分流管理。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To investigate the dynamic characteristics of human papillomavirus (HPV) genomic integration during cervical lesion progression and the clinical value of HPV integration detection in stratify HPV-positive women, and to explore its molecular mechanisms in cervical carcinogenesis. Methods: A prospective cohort study was designed to enroll high-risk HPV (HR-HPV) positive women who underwent cervical cancer screening in Drum Tower Hospital Affiliated to Nanjing University Medical School and Nanjing Maternity and Child Health Care Hospital from July 2022 to July 2024. Cervical exfoliated cells samples were collected, and HPV whole genome targeted capture and high-throughput sequencing technology were used. The HPV integration patterns, host gene functional region distribution and pathway enrichment characteristics of 157 samples with different cervical lesions grades were analyzed, including 31 cases of normal cervix, 40 cases of cervical intraepithelial neoplasia (CIN) Ⅰ, 32 cases of CIN Ⅱ, 42 cases of CIN Ⅲ, and 12 cases of cervical cancer. Results: HR-HPV integration was detected in 80.2% (126/157) of the 157 HR-HPV positive samples. The incidence of HR-HPV integration in cervical cancer patients was 12/12, which was higher than that in normal women (77%, 24/31). The incidence of HPV16 integration was significantly higher in high-grade lesions, and the incidence of HPV16 integration was 43% (18/42) in CIN Ⅲ patients and 8/12 in cervical cancer patients (P<0.001). A total of 14 438 integration events were detected in 126 samples with HPV integration. The integration sites were mainly distributed in the host intergenic region (51.0%, 7 359/14 438) and intronic region (38.1%, 5 494/14 438), and the integration frequency of viral L1 gene was the highest (28.4%, 4 498/16 781). Functional enrichment analysis showed that HPV integration-related host genes were significantly enriched in transport of small molecules,cyclic guanosine monophosphate (cGMP)-protein kinase G (PKG) signaling pathway, and purine ribonucleotide biosynthetic process, which synergistically drove carcinogenesis through multiple mechanisms. Conclusions: HPV integration events are significantly associated with the progression of cervical lesions. HPV integrated detection based on cervical exfoliated cells is expected to optimize the current screening strategy, reduce excessive intervention of HPV positive women and facilitate their accurate triage management. 目的: 评估人乳头状瘤病毒(HPV)整合检测在HPV阳性妇女分流管理中的潜在应用价值,并探讨其在子宫颈癌发生发展过程中的潜在分子机制。 方法: 采用前瞻性队列研究设计,纳入2022年7月至2024年7月于南京大学医学院附属鼓楼医院及南京市妇幼保健院接受子宫颈癌筛查的高危型HPV(HR-HPV)阳性妇女,收集子宫颈脱落细胞样本,应用HPV全基因组靶向捕获和高通量测序技术,分析HPV阳性妇女[共157例,包括正常31例、子宫颈上皮内瘤变(CIN)Ⅰ 40例、CINⅡ 32例、CINⅢ 42例、子宫颈癌12例]样本的HPV整合模式、宿主基因功能区域分布及通路富集特征。 结果: 在157例HR-HPV阳性样本中,80.2%(126/157)检出HR-HPV整合,且整合发生率在子宫颈癌患者中为12/12,高于正常妇女(77%,24/31)。HPV16型的整合发生率在高级别病变中显著升高(P<0.001),其在CINⅢ患者中的整合发生率为43%(18/42),子宫颈癌患者的整合发生率为8/12,但在正常妇女中仅为13%(4/31)。126例发生HPV整合的样本中,共检出14 438个整合发生事件。整合位点主要分布于宿主基因间区(51.0%,7 359/14 438)和内含子区(38.1%,5 494/14 438),HPV整合位点附近的HPV病毒L1基因整发生频率最高(28.4%,4 498/16 781)。HPV整合位点相关的宿主基因功能注释及通路富集分析显示,HPV整合相关宿主基因显著富集于小分子转运、环磷酸鸟苷-蛋白激酶G信号通路、嘌呤核苷酸生物合成过程,通过多机制协同驱动癌变。 结论: HPV整合事件与子宫颈病变进展显著相关,基于子宫颈脱落细胞的HPV整合检测有望优化现有筛查策略,减少HPV阳性妇女的过度干预并利于其精准分流管理。.
引用
- Li JJ, Guan WY, Chu CZ, et al. [Potential value of HPV integration testing in a triage management for HPV-positive women]. Zhonghua Fu Chan Ke Za Zhi. 2025. PMID: 41167779. doi:10.3760/cma.j.cn112141-20250320-00094
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。